By Louis Garguilo, Chief Editor, Outsourced Pharma
It was time within our greater ruminations on China (see outsourcedpharma.com) to speak directly with a quality executive at a drug developer and manufacturer based there. That’s now been accomplished via a discussion with Diana Francis, VP of quality and compliance for BeiGene.
BeiGene is a biopharma developing and commercializing cancer drugs for global markets. It has been dubbed as a potential “Genentech of China.” The company also has locations in the U.S., Australia, and Europe.